ScholarWorks@Gyeongsang National University

Browsing by Sym, Sun JinAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 8 of 8

SCIESCOPUS
Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG)open access

Jung, Minkyu; Ryu, Min-Hee; Oh, Do Youn; Kang, Myounghee; Zang, Dae Young; Hwang, In Gyu; Lee, Keun-Wook; Kim, Ki Hyang; Shim, Byoung Yong; Song, Eun Kee, et al.

ArticleIssue Date2018CitationGASTRIC CANCER, v.21, no.5, pp 819 - 830PublisherSPRINGER
SCIESCOPUS
Gemcitabine and Cisplatin Plus Polymeric Micellar Paclitaxel and Survival in Advanced Biliary Tract Cancer A Randomized Clinical Trialopen access

Jeong, Hyehyun; Yoo, Changhoon; Kim, Ilhwan; Kang, Jung Hun; Jeong, Jae Ho; Park, Kwonoh; Oh, Sang-Bo; Park, Inkeun; Sym, Sun Jin; Cheon, Jaekyung, et al.

ArticleIssue Date2025CitationJAMA Network Open, v.8, no.10PublisherAMER MEDICAL ASSOC
SCIESCOPUS
Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3)

Go, Se-Il; Lee, Sang-Cheol; Bae, Woo Kyun; Zang, Dae Young; Lee, Hyun Woo; Jang, Joung Soon; Ji, Jun Ho; Kim, Jung Hoon; Park, Sanggon; Sym, Sun Jin, et al.

ArticleIssue Date2021CitationEuropean Journal of Cancer, v.157, pp 21 - 30PublisherPergamon Press Ltd.
SCIESCOPUS
Modified FOLFIRINOX versus S-1 as second-line chemotherapy in patients with gemcitabine-failed metastatic pancreatic cancer: A randomized phase III trial (MPACA-3).

Go, Se-Il; Lee, Sang-Cheol; Bae, Woo Kyun; Zang, Dae Young; Lee, Hyun Woo; Jang, Joung Soon; Ji, Jun Ho; Kim, Jung Hoon; Park, Sanggon; Sym, Sun Jin, et al.

ArticleIssue Date2021CitationJournal of Clinical Oncology, v.39, no.15PublisherAmerican Society of Clinical Oncology
SCIESCOPUS
Multicenter phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab

Kim, Hyung-Don; Sym, Sun Jin; Chon, Hong Jae; Kim, Moonho; Kang, Jung Hun; Ryoo, Baek-Yeol; Lee, Choong-kun; Hong, Joohyun; Ryu, Hyewon; Bae, Woo Kyun, et al.

ArticleIssue Date2025CitationJournal of HepatologyPublisherElsevier BV
SCIESCOPUS
Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07open access

Kim, Seung Tae; Kim, Sun Young; Lee, Jeeyun; Yun, Seong Hyeon; Kim, Hee Cheol; Lee, Woo Yong; Kim, Tae Won; Hong, Yong Sang; Lim, Seok-Byung; Baek, Ji Yeon, et al.

ArticleIssue Date2022CitationJournal of Clinical Oncology, v.40, no.33, pp 3868 - 3877PublisherAmerican Society of Clinical Oncology
SCIESCOPUS
Quality of life outcomes in terminal cancer patients attending regional cancer centers in South Korea: protocol for a prospective cohort studyopen access

Kwon, Jung hye; Kang, Jung Hun; Huh, Jung-Sik; Koh, Su-Jin; Lim, Kyu-Hyoung; Choi, Byungho; Kim, Rock Bum; Choi, Young Jin; Song, Eun-Kee; Lee, Hyun Woo, et al.

ArticleIssue Date2024CitationBMC Cancer, v.24, no.1PublisherBioMed Central Ltd
SCIESCOPUS
Retrospective analysis of extra-gastrointestinal stromal tumorsopen access

Yi, Jun Ho; Park, Byeong-Bae; Kang, Jung Hun; Hwang, In Gyu; Shin, Dong Bok; Sym, Sun Jin; Ahn, Hee Kyung; Lee, Soon Il; Lim, Do Hyoung; Park, Keon Woo, et al.

ArticleIssue Date2015CitationWORLD JOURNAL OF GASTROENTEROLOGY, v.21, no.6, pp 1845 - 1850PublisherBAISHIDENG PUBLISHING GROUP INC
1

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532

COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어